Glassman Robert exercised Options for 8,667 Pharvaris shares at $22.31 per share and sold 8,667 shares at $38.27 on 2026-09-15. For investors, the disclosure identifies resulting share holdings of 19,167 and 10,500, alongside zero derivative securities after the related exercise.

Key Highlights

  • The option exercise was priced at $22.31 per share on 15 September 2026.
  • The sale left Glassman Robert with 10,500 Pharvaris shares.
  • Derivative securities fell to 0 after an exercise representing about 100.0% of the prior holding.

He sold shares at $38.27 per share that day, making the reported activity a share option exercise and a separate sale involving Pharvaris.

Pharvaris Share Holdings After the Transactions

The option exercise resulted in reported ownership of 19,167 shares, with the transaction representing about 45.2% of Robert’s resulting share holding. The sale involved 8,667 shares and left him with 10,500 shares. That transaction represented about 45.2% of his prior share holding. SEC transaction code M identifies an option exercise, while code S identifies a sale. The per-share prices apply to the separate share transactions, rather than to the derivative securities entry.

Derivative Securities Exercise

The transaction represented about 100.0% of his prior derivative-securities holding. The entry also used SEC transaction code M, distinguishing the exercise from the S-coded share sale. The reported records therefore cover two share transactions and one derivative-securities exercise.